ES2104770T3 - Metodo para diagnosticar enfermedades renales por deteccion de fragmentos de albumina. - Google Patents

Metodo para diagnosticar enfermedades renales por deteccion de fragmentos de albumina.

Info

Publication number
ES2104770T3
ES2104770T3 ES92108689T ES92108689T ES2104770T3 ES 2104770 T3 ES2104770 T3 ES 2104770T3 ES 92108689 T ES92108689 T ES 92108689T ES 92108689 T ES92108689 T ES 92108689T ES 2104770 T3 ES2104770 T3 ES 2104770T3
Authority
ES
Spain
Prior art keywords
detection
renal diseases
albumin fragments
fragments
diagnosing renal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92108689T
Other languages
English (en)
Inventor
Hirokazu Suzuki
Yoshinori Sakurai
Yoshitami Ohashi
Masayoshi Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4105214A external-priority patent/JPH05302922A/ja
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2104770T3 publication Critical patent/ES2104770T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN METODO PARA DIAGNOSTICAR ENFERMEDADES RENALES MEDIANTE LA DETECCION DE FRAGMENTOS DE ALBUMINA EN LA ORINA HUMANA. LA DETECCION DE LOS FRAGMENTOS SE REALIZA MEDIANTE, POR EJEMPLO, METODOS INMUNOLOGICOS O TECNICAS DE CROMATOGRAFIA LIQUIDA. EL METODO DE LA PRESENTE INVENCION ES UTIL PARA EL DIAGNOSTICO DE DIFERENTES ENFERMEDADES RENALES Y CAPAZ DE DIAGNOSTICAR LAS ENFERMEDADES EN UNA ETAPA ANTERIOR DEL MISMO COMPARADO CON METODOS DE DIAGNOSTICO CONVENCIONALES.
ES92108689T 1991-05-24 1992-05-22 Metodo para diagnosticar enfermedades renales por deteccion de fragmentos de albumina. Expired - Lifetime ES2104770T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14808091 1991-05-24
JP4105214A JPH05302922A (ja) 1991-05-24 1992-04-01 腎疾患の診断法

Publications (1)

Publication Number Publication Date
ES2104770T3 true ES2104770T3 (es) 1997-10-16

Family

ID=26445547

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92108689T Expired - Lifetime ES2104770T3 (es) 1991-05-24 1992-05-22 Metodo para diagnosticar enfermedades renales por deteccion de fragmentos de albumina.

Country Status (6)

Country Link
US (1) US5246835A (es)
EP (1) EP0514928B1 (es)
CA (1) CA2080250A1 (es)
DE (1) DE69221666T2 (es)
DK (1) DK0514928T3 (es)
ES (1) ES2104770T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US6475743B1 (en) * 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7297544B2 (en) * 1998-10-02 2007-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
AUPP784398A0 (en) 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
CN1331801A (zh) * 1998-12-21 2002-01-16 莫纳什大学 肾病检测及治疗
US20040029175A1 (en) * 1998-12-21 2004-02-12 Comper Wayne D. Method for kidney disease detection
DE19913940C1 (de) * 1999-03-26 2000-12-28 Univ Albert Ludwigs Freiburg Generelle Proteindetektion mittels Biotinilierung im Gel
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
WO2002037099A1 (fr) * 2000-10-27 2002-05-10 International Reagents Corporation Procede de diagnostic de la nephropathie
JP2004537036A (ja) * 2001-03-28 2004-12-09 ヘスカ コーポレイション 動物において早期腎疾患を検出する方法
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
US7482128B2 (en) * 2003-03-27 2009-01-27 Heska Corporation Anti-feline albumin antibodies
KR100882471B1 (ko) 2007-06-22 2009-02-09 고려대학교 산학협력단 당뇨병성 신증 진단용 바이오 마커 조성물
CN102221588A (zh) * 2011-02-24 2011-10-19 中南大学 一种用高效液相色谱法快速测定尿中微量白蛋白的方法
US9804154B2 (en) 2013-03-12 2017-10-31 Epinex Diagnostics, Inc. Rapid test for urine albumin and urine creatinine
CN117577321A (zh) 2017-08-08 2024-02-20 费森尤斯医疗保健控股公司 用于治疗和评估慢性肾脏疾病的进程的系统和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5480410A (en) * 1977-12-07 1979-06-27 Seikagaku Kogyo Co Ltd Corpuscle sensitized with anti-human-albumin-antibody, its preparation, and determination of human albumin using the same
JPS5719666A (en) * 1980-07-10 1982-02-01 Olympus Optical Co Ltd Fractionation treating method in electrophoresis
US4668363A (en) * 1984-03-16 1987-05-26 Beckman Instruments, Inc. Immunofixation electrophoresis process
JPS61230058A (ja) * 1985-04-04 1986-10-14 Susumu Kogyo Kk アルブミンの定量法
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex

Also Published As

Publication number Publication date
CA2080250A1 (en) 1992-11-25
EP0514928B1 (en) 1997-08-20
DK0514928T3 (da) 1997-10-20
US5246835A (en) 1993-09-21
DE69221666D1 (de) 1997-09-25
EP0514928A3 (en) 1993-02-24
DE69221666T2 (de) 1998-01-15
EP0514928A2 (en) 1992-11-25

Similar Documents

Publication Publication Date Title
ES2104770T3 (es) Metodo para diagnosticar enfermedades renales por deteccion de fragmentos de albumina.
Freedman et al. Gamma globulin and complement in the diseased kidney
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
NO972024L (no) Metoder for diagnostisering av glaukom
Wright et al. New antibody in early syphilis
Alegre et al. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
PL309637A1 (en) Diagnostic test and therapy for demyelination diseases such as multiple sclerosis
EP0291086A2 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten
RC et al. Histological and clinical evolution of lupus nephritis.
ATE106565T1 (de) Sandwich-immunotestverfahren für antigene bei ophthalmischen störungen.
Meadow Schönlein-Henoch syndrome.
Collier et al. The serum and conjunctival antibody response to trachoma in Gambian children
Wilkinson et al. Autoimmunity to human sweat. I. Demonstration of antigens in sweat reactive with autologous and homologous sera
SU1179999A1 (ru) Способ диагностики синдрома Ирвин-Гасса
Todd et al. Renal biopsy in 46 children with haematuria
Kalra et al. TIME TO ADD PROCALCITONIN AS AN ADJUNCT BIOMARKER IN DIAGNOSING BURN SEPSIS: A TERTIARY LEVEL CARE EXPERIENCE
SU650614A1 (ru) Способ радиоизотопной диагностики заболеваний почек
SU879370A1 (ru) Способ диагностики неврологических осложнений сифилиса
Janssen et al. Pathophysiology of the tear film: protein patterns in health and disease
SU1274682A1 (ru) Способ диагностики сальмонеллеза у детей
Shapiro et al. Clinical remission of purpura hyperglobulinemica
Vernier Chronic Glomerulonephritis and the Nephrotic Syndrome
Brewer et al. An indirect enzyme-linked immunosorbent assay for the detection of antibodies to Brucella abortus in porcine sera

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 514928

Country of ref document: ES